Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-23-000415
Filing Date
2023-03-22
Accepted
2023-03-22 16:57:09
Documents
92
Period of Report
2023-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bmmj_10q.htm   iXBRL 10-Q 1382769
2 CERTIFICATION bmmj_ex311.htm EX-31.1 11987
3 CERTIFICATION bmmj_ex312.htm EX-31.2 12091
4 CERTIFICATION bmmj_ex321.htm EX-32.1 4329
  Complete submission text file 0001640334-23-000415.txt   7160381

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bmmj-20230131.xsd EX-101.SCH 86760
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmmj-20230131_lab.xml EX-101.LAB 418641
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bmmj-20230131_cal.xml EX-101.CAL 65130
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmmj-20230131_pre.xml EX-101.PRE 377371
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmmj-20230131_def.xml EX-101.DEF 247985
86 EXTRACTED XBRL INSTANCE DOCUMENT bmmj_10q_htm.xml XML 1184127
Mailing Address 750 - 1095 WEST PENDER STREET VANCOUVER A1 V6E 2M6
Business Address 750 - 1095 WEST PENDER STREET VANCOUVER A1 V6E 2M6 604-376-3567
BODY & MIND INC. (Filer) CIK: 0001715611 (see all company filings)

EIN.: 981319227 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-55940 | Film No.: 23753558
SIC: 2834 Pharmaceutical Preparations